The global campaign to encourage the use of biosimilars comes at an interesting time in Australia with the most recent changes appearing to suggest policymakers are moving away from uptake as a driver of lower prices.
Global push to raise awareness of biosimilars as some policymakers appear to give up
November 14, 2022 Latest NewsBioPharma
Latest Video
New Stories
-
New digital health reforms to give Australians a more complete medicines history
January 28, 2026 - - Latest News -
Peer-reviewed validation strengthens Paradigm’s osteoarthritis program
January 28, 2026 - - Australian Biotech -
Obesity medicines, the limits of the PBS, and the test of policy imagination
January 28, 2026 - - Latest News -
Patrys completes Reliis acquisition, expands clinical pipeline and strengthens board
January 28, 2026 - - Australian Biotech -
Trump administration launches third round of price negotiations, including the first renegotiation
January 28, 2026 - - Latest News -
UK life sciences report highlights pressures familiar to Australian industry
January 27, 2026 - - Latest News -
Americans pay a much lower share of health costs than we do in Australia
January 27, 2026 - - Latest News

